Latest filing published 11 Jun 2024 for Genmab A/S, €1,539.
Anders Gersel Pedersen appears at Genmab A/S, a Danish company, in 15 filings published between December 5, 2012 and June 11, 2024. Seven are sales, totalling EUR 4,811,155 with a median of EUR 60,662; eight are of another nature. No purchase is recorded, and the record holds neither grants nor option exercises.
Two sales dominate: EUR 2,326,682 on September 30, 2020 and EUR 2,189,111 on February 26, 2020. The next, EUR 198,218 on May 18, 2021, is far smaller. The first filing of the record was published on December 5, 2012, and the latest on June 11, 2024; 2012, 2014 and 2024 hold one filing each. The year 2020 holds three filings, as does 2016; 2015, 2021 and 2022 hold two each. None fell in the last twelve months.
Filings arrive very quickly, a median of one day after the trade. The count of trades by Pedersen within 30 days of colleagues at Genmab A/S is 3, 1 and 1, all on the same side. In the same order, the colleagues are Jan van de Winkel, Anthony Pagano and Judith Klimovsky.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations